BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 10916678)

  • 1. Red cell pyruvate kinase deficiency: from genetics to clinical manifestations.
    Zanella A; Bianchi P
    Baillieres Best Pract Res Clin Haematol; 2000 Mar; 13(1):57-81. PubMed ID: 10916678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red cell pyruvate kinase deficiency: molecular and clinical aspects.
    Zanella A; Fermo E; Bianchi P; Valentini G
    Br J Haematol; 2005 Jul; 130(1):11-25. PubMed ID: 15982340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From gene to disease; hereditary non-spherocytic hemolytic anemia caused by pyruvate kinase deficiency].
    de Vooght KM; van Wijk R; Nieuwenhuis HK; Ploos van Amstel JK; Rijksen G; van Solinge WW
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1828-31. PubMed ID: 12382367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate kinase deficiency: the genotype-phenotype association.
    Zanella A; Fermo E; Bianchi P; Chiarelli LR; Valentini G
    Blood Rev; 2007 Jul; 21(4):217-31. PubMed ID: 17360088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hereditary haemolytic anaemia due to pyruvate kinase deficiency. Prognosis of neonatal forms (author's transl)].
    Boivin P; Ottenwaelter T
    Nouv Presse Med; 1982 Mar; 11(12):917-9. PubMed ID: 7063368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia.
    Wang C; Chiarelli LR; Bianchi P; Abraham DJ; Galizzi A; Mattevi A; Zanella A; Valentini G
    Blood; 2001 Nov; 98(10):3113-20. PubMed ID: 11698298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary structure of murine red blood cell-type pyruvate kinase (PK) and molecular characterization of PK deficiency identified in the CBA strain.
    Kanno H; Morimoto M; Fujii H; Tsujimura T; Asai H; Noguchi T; Kitamura Y; Miwa S
    Blood; 1995 Oct; 86(8):3205-10. PubMed ID: 7579416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of pyruvate kinase deficiency among Tunisians: description of new mutations affecting coding and noncoding regions in the PKLR gene.
    Jaouani M; Manco L; Kalai M; Chaouch L; Douzi K; Silva A; Macedo S; Darragi I; Boudriga I; Chaouachi D; Fitouri Z; Van Wijk R; Ribeiro ML; Abbes S
    Int J Lab Hematol; 2017 Apr; 39(2):223-231. PubMed ID: 28133914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and clinical heterogeneity in pyruvate kinase deficiency in India.
    Warang P; Kedar P; Ghosh K; Colah R
    Blood Cells Mol Dis; 2013 Oct; 51(3):133-7. PubMed ID: 23770304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate kinase deficiency.
    Miwa S; Fujii H
    Clin Biochem; 1990 Apr; 23(2):155-7. PubMed ID: 2197027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell PK deficiency: An update of PK-LR gene mutation database.
    Canu G; De Bonis M; Minucci A; Capoluongo E
    Blood Cells Mol Dis; 2016 Mar; 57():100-9. PubMed ID: 26832193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of the PK-LR gene in sixteen pyruvate kinase-deficient patients.
    Zanella A; Bianchi P; Fermo E; Iurlo A; Zappa M; Vercellati C; Boschetti C; Baronciani L; Cotton F
    Br J Haematol; 2001 Apr; 113(1):43-8. PubMed ID: 11328279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary erythrocyte pyruvate-kinase (PK) deficiency and chronic hemolytic anemia: clinical, genetic and molecular studies in six new Spanish patients.
    Vives-Corrons JL; Marie J; Pujades MA; Kahn A
    Hum Genet; 1980; 53(3):401-8. PubMed ID: 7372343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular heterogeneity of pyruvate kinase deficiency.
    Bianchi P; Fermo E
    Haematologica; 2020 Sep; 105(9):2218-2228. PubMed ID: 33054047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyruvate kinase deficiency.
    Miwa S
    Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1445-52. PubMed ID: 3328943
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.
    Grace RF; Bianchi P; van Beers EJ; Eber SW; Glader B; Yaish HM; Despotovic JM; Rothman JA; Sharma M; McNaull MM; Fermo E; Lezon-Geyda K; Morton DH; Neufeld EJ; Chonat S; Kollmar N; Knoll CM; Kuo K; Kwiatkowski JL; Pospíšilová D; Pastore YD; Thompson AA; Newburger PE; Ravindranath Y; Wang WC; Wlodarski MW; Wang H; Holzhauer S; Breakey VR; Kunz J; Sheth S; Rose MJ; Bradeen HA; Neu N; Guo D; Al-Sayegh H; London WB; Gallagher PG; Zanella A; Barcellini W
    Blood; 2018 May; 131(20):2183-2192. PubMed ID: 29549173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in pyruvate kinase.
    Beutler E; Baronciani L
    Hum Mutat; 1996; 7(1):1-6. PubMed ID: 8664896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual pyruvate kinase activity in PKLR-deficient erythroid precursors of a patient suffering from severe haemolytic anaemia.
    Klei TRL; Kheradmand Kia S; Veldthuis M; Beuger BM; Geissler J; Dehbozorgian J; Karimi M; van Bruggen R; van Zwieten R
    Eur J Haematol; 2017 Jun; 98(6):584-589. PubMed ID: 28295642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated pyruvate kinase activity in patients with hemolytic anemia due to red cell pyruvate kinase "deficiency".
    Beutler E; Forman L; Rios-Larrain E
    Am J Med; 1987 Nov; 83(5):899-904. PubMed ID: 3674096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red cell pyruvate kinase deficiency: adverse effect of oral contraceptives.
    Kendall AG; Charlow GF
    Acta Haematol; 1977; 57(2):116-20. PubMed ID: 402766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.